Simultaneous determination of naltrexone and bupropion in their co-formulated tablet utilizing green chromatographic approach with application to human urine
A rapid, simple and accurate micellar HPLC-method was adopted and validated for concurrent quantification of naltrexone hydrochloride (NTX) and bupropion hydrochloride (BUP). The proposed method was conducted on RP-18 LiChrosorb® column (150 mm × 4.6 mm i.d. 5-µm particle size) at 25 °C, as a statio...
Saved in:
Main Authors: | Sherif A. Abdel-Gawad (Author), Rania M. El-Gamal (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2018-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Naltrexone and Bupropion Combination Treatment for Smoking Cessation and Weight Loss in Patients With Schizophrenia
by: Xuechan Lyu, et al.
Published: (2018) -
Safety and Effectiveness of Naltrexone-Bupropion in Korean Adults with Obesity: Post-Marketing Surveillance Study
by: Lyu YS, et al.
Published: (2024) -
Naltrexone sustained-release/bupropion sustained-release for the management of obesity: review of the data to date
by: Caixàs A, et al.
Published: (2014) -
Promising Swellable Floating Bupropion Tablets: Formulation, in vitro/in vivo Evaluation and Comparative Pharmacokinetic Study in Human Volunteers
by: Teaima M, et al.
Published: (2020) -
Letter to the editor: naltrexone sustained-release/bupropion sustained-release for the management of obesity: review of the data to date
by: Buehler AM
Published: (2015)